Mediera Corporation (TPEX:5398)

Mediera Revenue

Mediera had revenue of 39.15M TWD in the quarter ending June 30, 2026, a decrease of -48.77%. This brings the company's total for the last twelve months to 195.89M, down -17.19% year-over-year. In the year 2025, Mediera had annual revenue of 229.85M, down -3.62%. That makes Mediera the 39,339th largest company in the world by revenue and 2,046th in Taiwan.

• Revenue (ttm): 195.89M
• Revenue Growth: -17.19%
• P/S Ratio: 4.42
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 865.64M

Revenue Chart

Chart

Chart

Revenue by Segment

Chart

• Physical Examination 129.88M 56.5%
• Pharmaceutical Biotechnology 99.97M 43.5%

Fiscal year ended Dec 31, 2025 See the full Mediera breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	229.85M	-8.64M	-3.62%
Dec 31, 2024	238.48M	45.59M	23.63%
Dec 31, 2023	192.90M	-64.65M	-25.10%
Dec 31, 2022	257.55M	-94.01M	-26.74%
Dec 31, 2021	351.56M	-16.33M	-4.44%

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 20, 2026

Data Sources Report a data error